Keywords:
SARS CоV-2, пневмония, сахарный диабет 2 типа, пневмония, интерферон.References
Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovasculardisease // Circulation. 2020. Vol. 141. P. 1648–1655. DOI: https://doi. org/10.1161/ CIRCULATIONAHA. 120.046 941
Clerkin K.J., Fried J.A., Raikhelkar J., Sayer G., Griffin J.M., Masoumi A. et al. Coronavirus disease 2019 (COVID-19) and cardiovasculardisease // Circulation. 2020. Vol. 141. P. 1648–1655. DOI: https://doi.org /10.1161/CIRCULATIONAHA.120.046941
Guo W., Li M., Dong Y., Zhou H., Zhang Z., Tian C. Diabetes is a riskfactor for the progression and prognosis of COVID-19 // Diabetes Metab. Res.Rev. 2020. Mar 31. Article ID e3319. DOI: https://doi.org/10. 1002/dmrr.3319
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features ofpatients infected with 2019 novel coronavirus in Wuhan, China // Lancet.2020. Vol. 395. P. 497–506
Huang C., Wang Y., Li X., Ren L., Zhao J., Hu Y. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China // Lancet.2020. Vol. 395. P. 497–506
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.,2020; Chen G, Wu D, Guo W, Cao Y, Huang D, Wang H, et al.,2019
Huang C, Wang Y, Li X, Ren L, Zhao J, Hu Y, et al.,2020
H4ui DS, Zumla A,2019; Yin Y, Wunderink RG,2018; Hui DS, Memish ZA, Zumla A.,2014; Badawi A, Ryoo SG.,2016]
Hui DS, Zumla A.,2019; Yin Y, Wunderink RG.2018; Hui DS, Memish ZA, Zumla A,2014
Jeong I.K., Yoon K.H., Lee M.K. Diabetes and COVID-19: global andregional perspectives // Diabetes Res. Clin. Pract. 2020. Vol. 166. ArticleID 108303. PMCID: PMC 7332438 PMID: 32623038
Richardson S., Hirsch J.S., Narasimhan M., Crawford J.M., McGinn T.,Davidson K.W. et al.; the Northwell COVID-19 Research Consortium. Presenting characteristics, comorbidities, and outcomes among 5700 patientshospitalized with COVID-19 in the New York City Area // JAMA. 2020. Vol.323, N 20. P. 2052–2059. DOI: https://doi.org/10.1001/jama.2020. 6775Erratum in: JAMA. 2020. Vol. 323, N 20. P. 2098. PMID: 32320003; PMCID:PMC 7177629]
Russell B, Moss C, Rigg A, Hemelrijck MV. COVID-19 andtreatment with NSAIDs and corticosteroids: should we belimiting their use in the clinical setting? Ecancer. 2020;14:1023.doi: https://doi.org /10.3332/ecancer.2020.1023].
Roncon L., Zuin M., Rigatelli G., Zuliani G. Diabetic patients withCOVID-19 infection are at higher risk of ICU admission and poor shorttermoutcome // J. Clin. Virol. 2020. Vol. 127. Article ID 104354
World Health Organization Coronavirus Disease (COVID-2019) Situation Reports 158. Geneva: WHO; (2020). [Google Scholar
World Health Organization Naming the coronavirus disease (COVID-19) and the virus that causes it [EB/OL] 2020-02-11. https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technicalguidance/naming-the-coronavirus-disease-(covid-2019)-and-the-virus-that-causesit [Ref list]
World Health Organization Coronavirus disease 2019 (COVID-19) situation report – 92. https://www.who.int/docs/ default-source / coronaviruse / situation reports 20200421-sitrep-92-covid-19.pdf? sfvrsn=38e6b06d_6
Zhao Z, Zhang F, Xu M, et al. De-scription and clinical treatmentof an early outbreak of severe acute respiratory syndrome (SARS)in Guangzhou, PR China. J Med Microbiol. 2013;52(Pt 8):715–720. https:// doi.org/10.1099/jmm.0.05320-0
Zhu L., She Z.G., Cheng X., Qin J.J., Zhang X.J., Cai J. et al. Association of blood glucose control and outcomes in patients withCOVID-19 and pre-existing type 2 diabetes // Cell Metab. 2020. Vol. 31,N 6. P. 1068–1077.e3. DOI: https://doi.org/10. 1016/j.cmet.2020.04.021PMID: 32369736; PMCID: PMC 7252168
Всемирная организация здравоохранения (2018 г.) Глобальный доклад о диабете. https:// www.who.int / news-room/fact-sheets/detail/diabetes. По состоянию на 17 марта 2020 г.
Демидов Н.А., Андреева А.В., Анциферов М.Б. Сахарный диабет и COVID-19 в Москве: cтатус 2020 г. // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 2. C. 32–40. DOI: https://doi.org/ 10.33029/2304-9529-2021-10-2-32-40
Демидов Н.А., Андреева А.В., Анциферов М.Б. Сахарный диабет и COVID-19 в Москве: cтатус 2020 г. // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 2. C. 32–40. DOI: https://doi.org/ 10.33029/2304-9529-2021-10-2-32-40
Пономарева А.А. Прогностические факторы риска клинических исходов пациентов с сахарным диабетом 2 типа и новой коронавирусной инфекцией // Эндокринология: новости, мнения, обучение. 2021. Т. 10, № 3. C. 106–108. DOI: https://doi.org/10.33029/2304-9529-2021-10-3-106-108
Хайдарова Ф.А., Алиева А.В., Бердыкулова Д.М., Алимова Н.У., Халилова Д.З., Тожиева И.М. Структура смертности среди пациентов с сахарным диабетом в Республике Узбекистан во время пандемии COVID-19 // Сахарный диабет. —2022. — Т. 25. — №4. — С. 322-326. doi: https://doi.org/10.14341/DM12786С